Inflammatory biomarkers in patients with acute brain injuries

Glen C. Jickling

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Acute brain injury as a result of stroke and traumatic brain injury are leading causes of disability and mortality. Methods to improve patient diagnosis and prognosis for these common conditions are needed. Molecular biomarkers are one method that has been evaluated to diagnose acute brain injury, determine its cause, and predict outcomes and response to therapy. Markers that have been identified include a variety of proteins, nucleic acids, and lipids that relate to the pathophysiology of acute brain injury. Inflammation plays an important role in acute brain injury and several molecules involved in inflammation have been identified as biomarkers. However, biomarkers for acute brain injury is a developing field that requires additional study is to identify markers for use in clinical practice. These studies will include evaluating a larger number of candidate markers using proteomic, genomic, metabolomic, and lipidomic approaches. Additionally, novel markers such as microRNA and the use of panels that integrate multiple markers may also prove to be valuable tools in acute brain injury. In this chapter, we provide a summary of identified inflammatory biomarkers in acute brain injury, and how these biomarkers could add to patient care.

Original languageEnglish (US)
Title of host publicationImmunological Mechanisms and Therapies in Brain Injuries and Stroke
PublisherSpringer New York
Pages211-234
Number of pages24
ISBN (Electronic)9781461489153
ISBN (Print)9781461489146
DOIs
StatePublished - Jan 1 2014

Fingerprint

Brain Injuries
Biomarkers
Inflammation
Metabolomics
MicroRNAs
Proteomics
Nucleic Acids
Patient Care
Stroke
Lipids
Mortality
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Jickling, G. C. (2014). Inflammatory biomarkers in patients with acute brain injuries. In Immunological Mechanisms and Therapies in Brain Injuries and Stroke (pp. 211-234). Springer New York. https://doi.org/10.1007/978-1-4614-8915-3_12

Inflammatory biomarkers in patients with acute brain injuries. / Jickling, Glen C.

Immunological Mechanisms and Therapies in Brain Injuries and Stroke. Springer New York, 2014. p. 211-234.

Research output: Chapter in Book/Report/Conference proceedingChapter

Jickling, GC 2014, Inflammatory biomarkers in patients with acute brain injuries. in Immunological Mechanisms and Therapies in Brain Injuries and Stroke. Springer New York, pp. 211-234. https://doi.org/10.1007/978-1-4614-8915-3_12
Jickling GC. Inflammatory biomarkers in patients with acute brain injuries. In Immunological Mechanisms and Therapies in Brain Injuries and Stroke. Springer New York. 2014. p. 211-234 https://doi.org/10.1007/978-1-4614-8915-3_12
Jickling, Glen C. / Inflammatory biomarkers in patients with acute brain injuries. Immunological Mechanisms and Therapies in Brain Injuries and Stroke. Springer New York, 2014. pp. 211-234
@inbook{4af68a7a47924b309a801901cc4d29d4,
title = "Inflammatory biomarkers in patients with acute brain injuries",
abstract = "Acute brain injury as a result of stroke and traumatic brain injury are leading causes of disability and mortality. Methods to improve patient diagnosis and prognosis for these common conditions are needed. Molecular biomarkers are one method that has been evaluated to diagnose acute brain injury, determine its cause, and predict outcomes and response to therapy. Markers that have been identified include a variety of proteins, nucleic acids, and lipids that relate to the pathophysiology of acute brain injury. Inflammation plays an important role in acute brain injury and several molecules involved in inflammation have been identified as biomarkers. However, biomarkers for acute brain injury is a developing field that requires additional study is to identify markers for use in clinical practice. These studies will include evaluating a larger number of candidate markers using proteomic, genomic, metabolomic, and lipidomic approaches. Additionally, novel markers such as microRNA and the use of panels that integrate multiple markers may also prove to be valuable tools in acute brain injury. In this chapter, we provide a summary of identified inflammatory biomarkers in acute brain injury, and how these biomarkers could add to patient care.",
author = "Jickling, {Glen C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-8915-3_12",
language = "English (US)",
isbn = "9781461489146",
pages = "211--234",
booktitle = "Immunological Mechanisms and Therapies in Brain Injuries and Stroke",
publisher = "Springer New York",

}

TY - CHAP

T1 - Inflammatory biomarkers in patients with acute brain injuries

AU - Jickling, Glen C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Acute brain injury as a result of stroke and traumatic brain injury are leading causes of disability and mortality. Methods to improve patient diagnosis and prognosis for these common conditions are needed. Molecular biomarkers are one method that has been evaluated to diagnose acute brain injury, determine its cause, and predict outcomes and response to therapy. Markers that have been identified include a variety of proteins, nucleic acids, and lipids that relate to the pathophysiology of acute brain injury. Inflammation plays an important role in acute brain injury and several molecules involved in inflammation have been identified as biomarkers. However, biomarkers for acute brain injury is a developing field that requires additional study is to identify markers for use in clinical practice. These studies will include evaluating a larger number of candidate markers using proteomic, genomic, metabolomic, and lipidomic approaches. Additionally, novel markers such as microRNA and the use of panels that integrate multiple markers may also prove to be valuable tools in acute brain injury. In this chapter, we provide a summary of identified inflammatory biomarkers in acute brain injury, and how these biomarkers could add to patient care.

AB - Acute brain injury as a result of stroke and traumatic brain injury are leading causes of disability and mortality. Methods to improve patient diagnosis and prognosis for these common conditions are needed. Molecular biomarkers are one method that has been evaluated to diagnose acute brain injury, determine its cause, and predict outcomes and response to therapy. Markers that have been identified include a variety of proteins, nucleic acids, and lipids that relate to the pathophysiology of acute brain injury. Inflammation plays an important role in acute brain injury and several molecules involved in inflammation have been identified as biomarkers. However, biomarkers for acute brain injury is a developing field that requires additional study is to identify markers for use in clinical practice. These studies will include evaluating a larger number of candidate markers using proteomic, genomic, metabolomic, and lipidomic approaches. Additionally, novel markers such as microRNA and the use of panels that integrate multiple markers may also prove to be valuable tools in acute brain injury. In this chapter, we provide a summary of identified inflammatory biomarkers in acute brain injury, and how these biomarkers could add to patient care.

UR - http://www.scopus.com/inward/record.url?scp=85028540112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028540112&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8915-3_12

DO - 10.1007/978-1-4614-8915-3_12

M3 - Chapter

AN - SCOPUS:85028540112

SN - 9781461489146

SP - 211

EP - 234

BT - Immunological Mechanisms and Therapies in Brain Injuries and Stroke

PB - Springer New York

ER -